Published in Hepatology on June 01, 2010
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (2011) 8.95
Current and future therapies for hepatitis C virus infection. N Engl J Med (2013) 4.25
Hepatitis C, stigma and cure. World J Gastroenterol (2013) 1.13
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis. Int J Mol Sci (2014) 0.95
Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits. BMC Infect Dis (2015) 0.94
Chronic hepatitis C. Gut Liver (2011) 0.94
Hepatitis C cirrhosis: New perspectives for diagnosis and treatment. World J Hepatol (2015) 0.87
Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness. World J Gastroenterol (2016) 0.86
Long-term effects of antiviral therapy in patients with chronic hepatitis C. Hepat Res Treat (2010) 0.81
Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies. Clin Gastroenterol Hepatol (2013) 0.80
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatol Int (2016) 0.79
Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response. Dig Dis Sci (2015) 0.79
An overview of viral oncology in Italy - report from the Pavia meeting on solid tumors. Infect Agent Cancer (2012) 0.78
Hepatitis C: Treatment of difficult to treat patients. World J Hepatol (2015) 0.78
Is response-guided therapy being applied in the clinical setting? The hepatitis C example. Am Health Drug Benefits (2015) 0.78
Prevention of portal hypertension: from variceal development to clinical decompensation. Hepatology (2014) 0.77
Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response. Gut Liver (2016) 0.77
Treatment of patients with HCV related cirrhosis: many rewards with very few risks. Hepat Mon (2012) 0.77
Era of direct acting antivirals in chronic hepatitis C: Who will benefit? World J Hepatol (2015) 0.76
New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis. Hepat Med (2014) 0.75
Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort study. Medicine (Baltimore) (2016) 0.75
Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China. PLoS One (2017) 0.75
Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study. BMC Infect Dis (2015) 0.75
Is achievement of sustained virologic response an independent predictor or a cofactor for the development of esophageal varices? Hepatology (2010) 0.75
Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy. Clin Mol Hepatol (2016) 0.75
Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir. Biologics (2012) 0.75
Long-term effects of sustained virologic response on the development of esophageal varices in compensated cirrhosis: "is the bang worth the buck?". Hepatology (2010) 0.75
Direct-acting antiviral agents in patients with hepatitis C cirrhosis. Gastroenterol Hepatol (N Y) (2012) 0.75
Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C. World J Gastroenterol (2016) 0.75
The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection. Int J Hepatol (2011) 0.75
Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients. Clin Mol Hepatol (2013) 0.75
Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon. PLoS One (2016) 0.75
Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis. PLoS One (2014) 0.75
Impact of hepatitis C oral therapy in portal hypertension. World J Gastroenterol (2017) 0.75
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med (2003) 11.93
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol (2013) 4.21
Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol (2004) 3.87
Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology (2007) 3.73
Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol (2009) 3.67
Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg (2010) 3.61
Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med (2012) 3.27
Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol (2006) 3.26
Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women. J Natl Cancer Inst (2003) 3.20
Smoking and colorectal cancer: a meta-analysis. JAMA (2008) 3.19
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome. Hepatology (2002) 2.74
Tobacco smoking and cancer: a meta-analysis. Int J Cancer (2008) 2.64
MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer (2008) 2.37
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol (2003) 2.37
Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol (2006) 2.36
Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg (2008) 2.29
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology (2002) 2.18
Assessment of risk associated with specific fatty acids and colorectal cancer among French-Canadians in Montreal: a case-control study. Int J Epidemiol (2003) 2.11
Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia (2005) 2.03
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology (2004) 2.01
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Circulation (2005) 2.01
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat (2006) 1.99
Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology (2007) 1.98
Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy. J Natl Cancer Inst (2007) 1.97
Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results. J Thorac Cardiovasc Surg (2011) 1.94
Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol (2010) 1.93
Four-arm robotic lobectomy for the treatment of early-stage lung cancer. J Thorac Cardiovasc Surg (2009) 1.91
Complications, limitations, and failures of capsule endoscopy: a review of 733 cases. Gastrointest Endosc (2005) 1.86
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol (2003) 1.84
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med (2011) 1.83
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat (2007) 1.82
Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer (2002) 1.78
Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis (2009) 1.75
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial. J Hepatol (2007) 1.73
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood (2006) 1.69
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity. Breast Cancer Res Treat (2008) 1.62
Is response to antiviral treatment influenced by hepatitis B virus genotype? J Hepatol (2010) 1.61
Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia. Am J Gastroenterol (2005) 1.61
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat (2010) 1.59
Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology (2003) 1.59
The harmless acute pancreatitis score: a clinical algorithm for rapid initial stratification of nonsevere disease. Clin Gastroenterol Hepatol (2009) 1.58
ABO blood group and cancer. Eur J Cancer (2010) 1.57
Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria? Eur J Cardiothorac Surg (2011) 1.56
Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion (2005) 1.56
An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology (2009) 1.54
Video capsule enteroscopy in the diagnosis of celiac disease: a multicenter study. Am J Gastroenterol (2007) 1.53
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine. Hepatology (2004) 1.52
High serum creatinine in acute pancreatitis: a marker for pancreatic necrosis? Am J Gastroenterol (2009) 1.52
Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"? Breast (2013) 1.51
Literature review and recommendations for clinical application of Colon Capsule Endoscopy. Dig Liver Dis (2010) 1.50
High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer (2003) 1.49
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. Br J Haematol (2009) 1.49
Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatr Transplant (2012) 1.49
Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas (2008) 1.48
Evolution of emphysema in relation to smoking. Eur Radiol (2009) 1.47
Polymorphism in the CYP2D6 tamoxifen-metabolizing gene influences clinical effect but not hot flashes: data from the Italian Tamoxifen Trial. J Clin Oncol (2006) 1.47
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol (2005) 1.47
Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol (2004) 1.46
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg (2005) 1.45
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer (2008) 1.45
Environmental factors and risk of pancreatic cancer. Pancreatology (2003) 1.45
Natural history of acute pancreatitis: a long-term population-based study. Am J Gastroenterol (2009) 1.44
Small bowel capsule endoscopy in 2007: indications, risks and limitations. World J Gastroenterol (2007) 1.44
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol (2009) 1.43
Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites. J Hepatol (2002) 1.43
Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol (2004) 1.42
Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr (2008) 1.41
Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer (2005) 1.40
Immunosuppressive and biologic therapy for ulcerative colitis. Expert Opin Emerg Drugs (2012) 1.40
Fat Grafting after Invasive Breast Cancer: A Matched Case-Control Study. Plast Reconstr Surg (2017) 1.38
Risk factors for pancreatic cancer. J Cell Biochem (2005) 1.35
Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. Ann Surg Oncol (2011) 1.33
Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer (2009) 1.28
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial. Hepatology (2008) 1.26
Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. Am J Gastroenterol (2009) 1.25
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol (2006) 1.24
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol (2004) 1.24
Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging. Mod Pathol (2007) 1.23
Vitamin D and skin cancer: a meta-analysis. Eur J Cancer (2008) 1.22
A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology (2009) 1.22
How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys (2012) 1.21
Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev (2005) 1.21
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes. Breast Cancer Res (2014) 1.20
Ultrasound-guided vacuum-assisted core breast biopsy: experience with 406 cases. Breast Cancer Res Treat (2006) 1.20
The epidemiology and impact of pancreatic diseases in the United States. Curr Gastroenterol Rep (2005) 1.16
Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J Gastroenterol Hepatol (2007) 1.15
Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. World J Gastroenterol (2009) 1.15
Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg (2008) 1.14